Notice: This company has been marked as potentially delisted and may not be actively trading. CalAmp (CAMP) Stock Forecast & Price Target Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesInsider TradesOwnershipShort InterestSustainabilityTrends Get the Latest News and Ratings for CAMP and Related Stocks Enter your email address to receive the latest news and analysts' ratings for CalAmp and its competitors. Enter your email to sign up for newsletter Sign Up CAMP Analyst Ratings Over TimeTypeCurrent Forecast11/29/23 to 11/28/241 Month Ago10/30/23 to 10/29/243 Months Ago8/31/23 to 8/30/241 Year Ago11/29/22 to 11/29/23Strong Buy1 Strong Buy rating(s) N/A 0 Strong Buy rating(s)0 Strong Buy rating(s)Buy4 Buy rating(s) N/A 1 Buy rating(s)1 Buy rating(s)Hold0 Hold rating(s) N/A 1 Hold rating(s)2 Hold rating(s)Sell0 Sell rating(s) N/A 0 Sell rating(s)0 Sell rating(s)Consensus Price Target$19.33N/A$63.25$63.25Forecasted Upside312.22% UpsideN/A15,712.50% Upside715.78% UpsideConsensus RatingBuyN/AModerate BuyHold The latest trend in real estate (Ad)These vacation homes are often expensive to maintain and vacant 90% of the year. But thanks to co-ownership, they’re being transformed into fully utilized assets. And there’s one company that’s leading the charge – already welcoming over 1,500 happy homeowners into their co-ownership family, earning $100M in gross profits along the way. Now, for the first time, this innovative company is opening its doors to public investors. Want to learn more about co-ownership and its potential? Check them out – but be aware: their share price is set to change December 5, so you don’t have long to maximize your stake.Don’t miss your chance to maximize your stake in this co-ownership revolution. CAMP Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History CAMP Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table CalAmp Stock vs. The CompetitionTypeCalAmpMedical CompaniesS&P 500Consensus Rating Score 3.20 2.80 2.50Consensus RatingBuyModerate BuyModerate BuyPredicted Upside312.22% Upside24,682.80% Upside6.73% UpsideNews Sentiment RatingNeutral NewsSee Recent CAMP NewsPositive NewsPositive News Recent Analyst Forecasts and Stock Ratings All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Years 5 Years Time Frame Start Date End Date Most Recent from Each Brokerage All Show Export to Excel DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails11/5/2024Leerink Partnrs5 of 5 starsM. ForooharSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy11/5/2024Leerink Partners1 of 5 stars Initiated CoverageOutperform$17.00+106.81%11/5/2024William Blair2 of 5 starsM. MinterSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOutperform11/5/2024Piper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingE. TenthoffSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOverweight$18.00+118.98%11/5/2024JPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy rating Initiated CoverageOverweight$23.00+179.81%10/6/2023Roth MkmSubscribe to MarketBeat All Access for the recommendation accuracy rating Lower TargetBuy ➝ Buy$138.00 ➝ $115.00+1,332.66%10/6/2023Craig HallumSubscribe to MarketBeat All Access for the recommendation accuracy rating DowngradeBuy ➝ Hold$11.50+10.62%6/26/2023Jefferies Financial GroupSubscribe to MarketBeat All Access for the recommendation accuracy rating DowngradeBuy ➝ HoldAnalyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 02:49 PM ET. CAMP Forecast - Frequently Asked Questions What is CalAmp's forecast for 2025? According to the research reports of 5 Wall Street equities research analysts, the average twelve-month stock price forecast for CalAmp is $19.33, with a high forecast of $23.00 and a low forecast of $17.00. Should I buy or sell CalAmp stock right now? 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CalAmp in the last twelve months. There are currently 4 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" CAMP shares. Does CalAmp's stock price have much upside? According to analysts, CalAmp's stock has a predicted upside of 312.22% based on their 12-month stock forecasts. Has CalAmp been upgraded by Wall Street analysts recently? Over the previous 90 days, CalAmp's stock had 1 upgrade by analysts. What analysts cover CalAmp? CalAmp has been rated by research analysts at JPMorgan Chase & Co., Leerink Partners, Leerink Partnrs, Piper Sandler, and William Blair in the past 90 days. Do Wall Street analysts like CalAmp more than its competitors? Analysts like CalAmp more than other "medical" companies. The consensus rating for CalAmp is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how CAMP compares to other companies. Stock Forecasts and Research Tools Related Companies Aviat Networks Stock Forecast Comtech Telecommunications Stock Forecast Cisco Systems Stock Forecast QUALCOMM Stock Forecast Palo Alto Networks Stock Forecast Motorola Solutions Stock Forecast F5 Stock Forecast Juniper Networks Stock Forecast Ciena Stock Forecast EchoStar Stock Forecast Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top Rated Stocks Top Rated Stocks Top Rated Dividend Stocks Top Rated Small-Cap Stocks Top Rated Tech Stocks Most Upgraded Stocks Most Downgraded Stocks Lowest Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter The latest trend in real estate (Ad)These vacation homes are often expensive to maintain and vacant 90% of the year. But thanks to co-ownership, they’re being transformed into fully utilized assets. And there’s one company that’s leading the charge – already welcoming over 1,500 happy homeowners into their co-ownership family, earning $100M in gross profits along the way. Now, for the first time, this innovative company is opening its doors to public investors. Want to learn more about co-ownership and its potential? Check them out – but be aware: their share price is set to change December 5, so you don’t have long to maximize your stake.Don’t miss your chance to maximize your stake in this co-ownership revolution. This page (NASDAQ:CAMP) was last updated on 11/28/2024 by MarketBeat.com Staff From Our PartnersA “Thank You Gift” From Pres. Trump - GeniusTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredThe latest trend in real estateThese vacation homes are often expensive to maintain and vacant 90% of the year. But thanks to co-ownership, t...Pacaso | SponsoredYou’re invited! See my NEWEST trading strategyThis could easily be the most lucrative new trading strategy of 2025... So you’re not going to want to miss...Monument Traders Alliance | SponsoredTrump’s “Magic Pattern” targets stock market boomAccording to millionaire-trader Jeff Clark, President Trump's bold agenda is poised to unleash a historic trad...InvestorPlace | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | Sponsored140% Yields From Stocks Like Tesla? Here's How (Black Friday Special)140% Dividends from stocks like Tesla? Discover How for Just $9! For Black Friday, get the full details of ...Investors Alley | Sponsored9 hidden AI stocks set to thrive in Trump’s new eraAI ETFs are Booming, But These 9 AI Stocks are Better Plays By 2030, the AI industry is projected to be wor...StockEarnings | SponsoredThe Biggest Post-Election Market Shift Ever?Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CalAmp Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share CalAmp With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
